Q: There has been recent news (which I did not think was extremely material) but there seems to have been a very strong recovery based on this? Thoughts on this company in the near term and longer term?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi, Could you please comment on PHA earnings. Thank you
Q: Thoughts on auph and good recent momentum.Thanks.
Q: GUD's Statement of Cash Flows for the 3 months ended June 30, 2021 shows a 'Purchase of intangible assets' of $217 million, but I could not find an explanation for this significant investment in the MD&A. I would appreciate your comments on this item. Thank you. Edward
Q: Can you give me your update on Hamilton thorne.Would you start a position
Q: Hi. Can I get your opinion on this company? Do you think this is investible with the play/discretionary portion of our funds or do you think it's an out-right gamble? Thank you.
Q: Your comments on earnings please.
Sheldon
Sheldon
Q: Would appreciate your overall assessment of CloudMD (DOC) financial results for the 2nd Quarter that were released after the close today. Do you expect the share price will get a bounce. Thanks
Q: What do you prefer?
Pfizer
Moderna
Biontech
Pfizer
Moderna
Biontech
Q: I have checked earnings and your answers to questions which are now over a year , would your opinion be different re expected increased earnings going fwd …overall would u recommend or perhaps u have a more favourite stock in this category….thanks
Q: I bought AZN, last year at this time, at the same price it is trading now. Do you think there is any up side here, or should i just sell and move on.
Q: Hi, what's your opinion on Medical Facilities potential? It also has a decent dividend.
Q: Thoughts on QIPT’s recent quarterly financials please
Thanks
Thanks
Q: This is all hypothetical of course....
I bought a chunk of TRIL today...and arb play. Should I be worried about exchange rate friction? The take out price is US$18.50. As of today, that works out to about C$23.30.
Can currency movements wipe out the 5% gain I expect?
I bought a chunk of TRIL today...and arb play. Should I be worried about exchange rate friction? The take out price is US$18.50. As of today, that works out to about C$23.30.
Can currency movements wipe out the 5% gain I expect?
Q: Aurinia appears to have increasing revenue now and the question is how fast does it ramp up to increase the share price, I believe they have the goods so if this is true considering market capitalization and potential where could we see the share price when looking at the analyst estimates? There easily could be a buy out of this company so the question is after what upcoming event(s) would be the best timing for this. If they go it alone what does your experience tell you and can you put percentages on a guesstimate? Do you have any relevant Bloomberg script numbers? Also, do you think the company is currently worth the risk at the $13.64 a share. Your help is appreciated.
Q: Endo Pharma tanked on Friday (down one-third) after announcing the hiring of a Restructuring Advisor. Do you think they will survive?
Of course, this revives the "will Knight ger Paladin" question.
I have always thought Endo would never sell to Knight because they would be embarrassed after paying so much for the company to Goodman and Co...
I guess it's now if ever...
Of course, this revives the "will Knight ger Paladin" question.
I have always thought Endo would never sell to Knight because they would be embarrassed after paying so much for the company to Goodman and Co...
I guess it's now if ever...
Q: Hi, we have a small <1% holding in Well Health. Stock does not seem to gain traction over $7-$8 level, despite great news time to time, over past 2 years. I know, you have a lot of conviction in the company, based on the CEO's past record. Even the last news of their majority share holder and HK business tycoon, snapping company's shares @ $9.50, during a private placement. My question is that is the stock worth holding due to its growth potential ( despite not so impressive price movement ) and if so, do you believe, it could reach $9-$10 in next 1-2 years. Or, we should be patient, expecting a buyer, at some point in the future.
Thank You
Thank You
Q: Have followed this stock for years and never owned it I saw the G& Mail article on the recent executive change. Do you expect this event significant enough to purchase the stock, thinking that the pace of acquisitions will pick up ? Thanks Derek
Q: There is an in depth article on Knight, Samira Sakhia and Jonathan Goodman in yesterday's Globe and Mail. Would you post it for me? Not sure how:).
Very important info for Knight faithful (like me!).
Very important info for Knight faithful (like me!).
Q: Watched a very interesting interview with an analyst on BNN yesterday making the case for therapeutics as the way forward for battling new Covid variants (as opposed to MRNA booster shots). Made interesting points and suggested a few stocks. Two are very small but SRNE is a reasonably sized Co. What does the book look like for this one?
TIA
TIA